Venture Capital

After an ‘amazing year,’ SR One raises $600M to fuel more drug startups


Dive Brief:• SR One, the former venture arm of GSK, has raised its second fund since spinning out of the pharmaceutical company, announcing Monday a …

Read more

Show More

Related Articles

Back to top button